Colorcon launches Colorcon Academy
Industry leading further education programs unified and expanded.
Colorcon has launched the Colorcon Academy, an exciting new entity to build on the success of the company's highly valued education programs worldwide. Colorcon has provided speciality excipients for pharmaceutical and nutraceutical applications for nearly 60 years, and has always placed great emphasis to help customers optimize formulation development and manufacturing processes through its education events. The company's goal is to help clients achieve both outstanding technical and business outcomes.
Dr Ali Rajabi-Siahboomi, VP/Chief Scientific Officer, Colorcon said: “At Colorcon we are always striving to do something extra. This year, with the introduction of the Colorcon Academy, we’ve reorganized our highly valued education programs to advance our global standard in education. Under the new Colorcon Academy platform, we will offer the different programs at our 20 technical services facilities worldwide, in addition to events designed specifically for our customers, which are held at their site. Academy attendees have the opportunity to progress their skills in pharmaceutical sciences and become leaders in their own organizations at locations convenient to them.
"Since the first Colorcon Coating School in the 1980s, we have provided continuing education to thousands of customers around the world each year and continue to strengthen our commitment to advancing pharmaceutical technology and it’s applications.
"The Colorcon Academy program is designed to give pharmaceutical professionals a deeper knowledge of excipient functionality, core formulation, film coating and controlled release of oral solid dosage forms, along with regulatory insights; plus the opportunity to explore innovative solutions to formulation challenges.
"The thousands of course attendees have ranged from senior research scientists, to technology transfer scientists and process engineers. We receive very positive feedback from attendees and their managers, and continue to update and extend the content of the courses in line with changing industry needs. I am personally committed to the educational advances we provide and trust we continue to surpass attendees’ expectations with the launch of the Colorcon Academy,” concluded Dr Rajabi-Siahboomi.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance